How many insider declarations has Meng Lei filed?

Meng Lei has filed 1 public insider declaration with SEC (Form 4).

What is Meng Lei's role?

Meng Lei's reported role is not specified by the regulator across the filings.

Which companies does Meng Lei report trades for?

Meng Lei reports trades for Dianthus Therapeutics, Inc. /DE/.

← Executives ★ Sign in to follow

ML

Meng Lei

OFFICER

·SEC (Form 4)

Dianthus Therapeutics, Inc. /DE/

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Meng Lei. Director active across 1 company, notably Dianthus Therapeutics, Inc. /DE/. Aggregated, 1 filings have been published. Activity tracked since 22 January 2024. The latest transaction was filed on 22 January 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Meng Lei

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Dianthus Therapeutics, Inc. /DE/ (US)

申报1 总计

◆

Meng Lei

Director高管2024年1月22日Dianthus Therapeutics, Inc. /DE/

US$1800万19SEC ↗

1,500,000 股@ US$12.00100.0% 占其流量Common StockSEC:0000950170-24-007130:0

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

ML

Meng Lei

OFFICER

·SEC (Form 4)

Dianthus Therapeutics, Inc. /DE/

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Meng Lei. Director active across 1 company, notably Dianthus Therapeutics, Inc. /DE/. Aggregated, 1 filings have been published. Activity tracked since 22 January 2024. The latest transaction was filed on 22 January 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.